|
|
| Research article summary (published 30 Dec 1992): |
Somatostatin receptor scintigraphy in brain tumors and pituitary tumors: first experiences.
Full Abstract
Somatostatin receptors have been demonstrated on various tumors of neuroendocrine and other origin. They have been detected in vitro by biochemical techniques as well as by autoradiography. The development of long-acting somatostatin analogs and the recent availability of radiolabeled octreotide have made the in vivo detection of somatostatin receptors possible. This preliminary study embraced 45 patients with meningiomas, brain tumors or pituitary tumors, which were imaged by planar and tomographic scintigraphy after intravenous injection of 111Indium-labeled octreotide. In all of the meningiomas studied (unifocal and multifocal tumors in various locations), a high density of somatostatin receptors was detected by scintigraphy. Pituitary tumors were slightly positive in 50% of cases only, independent of the endocrine activity. Gliomas with an intact blood-brain barrier showed no enhanced tracer uptake in vivo, while gliomas with disturbed blood-brain barrier had a high activity uptake. We conclude that in vivo somatostatin receptor scintigraphy, although not tumor-specific, may aid in the preoperative diagnosis and staging of intracranial tumors, especially skull base tumors.
Author information
Author/s: Scheidhauer, K (K); Hildebrandt, G (G); Luyken, C (C); Schomäcker, K (K); Klug, N (N); Schicha, H (H);
Affiliation: Department of Nuclear Medicine, University of Cologne, Germany.
Journal and publication information
Publication Type: Journal Article
Journal: Hormone and metabolic research. Supplement series (Horm Metab Res Suppl), published in GERMANY. (Language: eng)
Reference: 1993-; vol 27 (issue ) : pp 59-62
Dates: Created 1993/08/13; Completed 1993/08/13; Revised 2007/07/23;
PMID: 8330874, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Indium Radioisotopes (0) ; Receptors, Somatostatin (0) ; Tumor Markers, Biological (0) ; SDZ 215-811 (142694-57-3) ; Pentetic Acid (67-43-6) ; Octreotide (83150-76-9) ; Growth Hormone (9002-72-6)Related articles
These are the most related articles currently in our database:
- [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
29 Nov 1995 - High sensitivity of the in vivo detection of somatostatin receptors by 111indium (DTPA-octreotide)-scintigraphy in meningioma patients.
30 Dec 1993 - Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs.
30 Dec 1992 - [The scintigraphy of somatostatin receptors in the carcinoid tumor]
30 Jan 2001 - Contribution of thallium-201-SPECT to the grading of tumorous alterations of the brain.
30 Dec 1991 - Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
18 Feb 2006 - Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
27 Jul 2006 - 111Indium (DTPA-octreotide) scintigraphy in patients with cerebral gliomas.
30 Dec 1993 - Noninvasive differentiation of meningiomas from other brain tumours using combined 111Indium-octreotide/99mtechnetium-DTPA brain scintigraphy.
30 Dec 1995
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.